openPR Logo
Press release

Roxatidine Market to boost its value by year 2023 : Allied Market Research

02-11-2019 02:31 PM CET | Health & Medicine

Press release from: Allied Market Research

Roxatidine Market

Roxatidine Market

Roxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or anti-ulcerant drug.

The increase in prevalence of people suffering from ulcers, low cost of the drug, and its ability to lower the acid production in the stomach is expected to increase the demand for the drug. However, certain side-effects of the drug such as chest pain, impotence, increased level of lipid in the blood, and gastrointestinal disturbances restraints the market growth.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4052

The global roxatidine market is segmented based on formulation, application, and region. Based on formulation, it is bifurcated into oral and injectable. Based on application, it is categorized into acidity, heartburn, intestinal ulcers, stomach ulcers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include Sanofi, Sun Pharmaceutical Industries Ltd., Sihuan Pharmaceutical Holdings Group Ltd., Cayman Chemical, A S Joshi & Company, Taj Pharmaceuticals Limited, and Amgen Inc.

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps determine the prevailing opportunities.
• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence the market on a global and regional scale are provided.
• Key market players are profiled and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the global market.

Roxatidine Market Key Segments:

By Formulation

• Oral
• Injectable

By Application

• Acidity
• Heartburn
• Intestinal Ulcers
• Stomach Ulcers
• Others

For More Info Visit @ https://www.alliedmarketresearch.com/request-toc-and-sample/4052

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Roxatidine Market to boost its value by year 2023 : Allied Market Research here

News-ID: 1577483 • Views: 198

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Roxatidine

Informative Report On (COVID-19 Updates) Roxatidine Market, Business Will Grow i …
According to a new report published by Allied Market Research, titled, "Roxatidine Market by Formulation (Oral and Injectable), and by Application (Acidity, Heartburn, Intestinal Ulcers, and Stomach Ulcers) - Global Opportunity Analysis and Industry Forecast, 2020-2027" The report has offered an all-inclusive analysis of the global Roxatidine Market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment pockets, future prospects, and trends. At the
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Impact of COVID-19 Outbreak on Roxatidine Market 2020| Worldwide Industry Share, …
Complete study of the global Roxatidine market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Roxatidine industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate
Roxatidine Market to show Rapid Growth During 2017-2023 : Allied Market Research
Roxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or anti-ulcerant drug. The increase in prevalence of people suffering from ulcers, low cost of the drug, and its ability to lower the acid production in the stomach is expected to increase the demand for the drug. However, certain side-effects
Roxatidine Market Size, Insights, Trends, Outlook 2018 | Top Key Players: Sanofi …
Roxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or anti-ulcerant drug. The Roxatidine report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios.
Global Antiulcer drugs Detailed Analysis market share by players, by regions, by …
The report "Global Antiulcer drugs Detailed Analysis Report 2017-2022 ", has been prepared based on an in-depth market analysis with inputs from industry experts. ​This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Antiulcer drugs industry. Get Sample copy of this Report @​